08:46 AM EDT, 06/06/2024 (MT Newswires) -- Health care stocks were steady premarket Thursday with the iShares Biotechnology ETF (IBB) and the Health Care Select Sector SPDR Fund (XLV) both recently unchanged.

Moderna ( MRNA ) shares were up more than 4% after the company said the US Food and Drug Administration has selected its experimental therapy, mRNA-3705, to treat methylmalonic acidemia, a rare genetic disorder, for a pilot program aimed at supporting clinical trials to advance rare disease therapeutics.